4th Quarter - Report
NOVOCURE INC. for NOVOCURE INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2023 | $120,000 | Replaced |
| 4th Quarter - Amendment | Feb 18, 2023 | $120,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General Medicare / Medicaid Issues. H.R.4043 - Ensuring Patient Access to Critical Breakthrough Products Act of 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY HAAS New | Senior Policy Advisor, Congressman Conor Lamb; Legislative Aide for Congresswoman Allyson Schwartz |
| KATHERINE MEYER | Senior Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senator Orrin Hatch; Sr. LA, Congressman Erik Paulsen; LA, Congressman Jeff Fortenberry |
Veterans VET
Veteran Affairs Issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY HAAS | — |
| KATHERINE MEYER | — |
Transportation TRA
TSA Issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY HAAS | — |
| KATHERINE MEYER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.